Tumeh et al. proposed a predictive model for PD-1 ICI response based on the invasive margin CD8+ T-cell density, which was validated in a separate patient cohort, indicating that the location of CD8+ T-cell infiltration within the tumor is of clinical importance (62). The gene discussed is CD8A; the disease is neoplasm.